2004Military Medical Journal of South ChinaRequires access

Control Study of Therapeutic Effects of Paroxetine and Amitriptyline on Patients with Schizophrenina Accompanying Depression and Anxiety

Li Yichen

Open publisher page 0 citations

Abstract

Objective To explore the clinical therapeutic effects and safety of paroxetine and amitriptyline in schixophreni-na patients with depression and anxiety.Method Sixty schixophrenina patients with depression and anxiety were divided into twogroups,i.e.the group treated by antischizophrenic durgs and paroxetine(32 cases)and the group treated by antischzophrenic drugsand amitfiptyline(28 cases).The theraphic effects on both the group were evaluated by HAMA,HAMD and Tess before the treat-ment,and 2,4,6 and 8 weeks after the treatment.Result There were insignificant difference in HAMD and HAMA between both thegroups 2,4,6 and 8 weeks afther the treatment(P0.05),but TESS was significantly lower in the group treated by antis-chizophrenic drugs and paroxetine than that in the group treated by antischizophrenc drugs and amitriptylime(P0.05).Conclu-sion The curative effect of paroxetine on depression and anxiety is significantly better and safer than that of amitriptyline.

About this research paper

What this paper is about

Objective To explore the clinical therapeutic effects and safety of paroxetine and amitriptyline in schixophreni-na patients with depression and anxiety.Method Sixty schixophrenina patients with depression and anxiety were divided into twogroups,i.e.the group treated by antischizophrenic durgs and paroxetine(32 cases)and the group treated by antischzophrenic drugsand amitfiptyline(28 cases).The theraphic effects on both the group were evaluated by HAMA,HAMD and Tess before the treat-ment,and 2,4,6 and 8 weeks after the treatment.Result There were insignificant difference in HAMD and HAMA between both thegroups 2,4,6 and 8 weeks afther the treatment(P0.05),but TESS was significantly lower in the group treated by antis-chizophrenic drugs and paroxetine than that in the group treated by antischizophrenc drugs and amitriptylime(P0.05).Conclu-sion The curative effect of paroxetine on depression and anxiety is significantly better and safer than that of amitriptyline.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical therapeutic effects and safety of paroxetine and amitriptyline in schixophreni-na patients with depression and anxiety.Method Sixty schixophrenina patients with depression and anxiety were divided into twogroups,i.e.the group treated by antischizophrenic durgs and paroxetine(32 cases)and the group treated by antischzophrenic drugsand amitfiptyline(28 cases).The theraphic effects on both the group were evaluated by HAMA,HAMD and Tess before the treat-ment,and 2,4,6 and 8 weeks after the treatment.Result There were insignificant difference in HAMD and HAMA between both thegroups 2,4,6 and 8 weeks afther the treatment(P0.05),but TESS was significantly lower in the group treated by antis-chizophrenic drugs and paroxetine than that in the group treated by antischizophrenc drugs and amitriptylime(P0.05).Conclu-sion The curative effect of paroxetine on depression and anxiety is significantly better and safer than that of amitriptyline.

Key concepts: Paroxetine, Hamd, Amitriptyline, Depression (economics), Anxiety, Medicine, Hamilton depression scale, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Control Study of Therapeutic Effects of Paroxetine and Amitriptyline on Patients with Schizophrenina Accompanying Depression and Anxiety — Research Paper | ScholarLens